ArticleInvestigative and clinical urology2024

IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma.

Se Un Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.